Radhakrishnan Renjith Kalathoorakathu, Mittal Bhagwant Rai, Gorla Arun Kumar Reddy, Basher Rajender Kumar, Sood Ashwani, Bal Amanjit, Kalra Naveen, Khandelwal Niranjan, Singh Navneet, Behera Digambar
1 Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2 Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Br J Radiol. 2017 Dec;90(1080):20170258. doi: 10.1259/bjr.20170258. Epub 2017 Oct 27.
The aim of this study was to assess the feasibility and appraise the diagnostic utility of real time F-FDG PET/CT-guided biopsy under automated robopsy arm (ARA) guidance for the evaluation of thoracic lesions with prior inconclusive biopsy results.
PET/CT-guided biopsy of thoracic lesions was performed in patients who had at least one previous inconclusive biopsy. A total of 25 patients (male:female-18 males, 7 females; age: range, 13-75; mean, 53.7) were included in this study. All these patients underwent percutaneous needle biopsies under real-time PET/CT guidance using ARA (ROBIO-EX, Perfint healthcare Pvt Ltd, Chennai, India) needle navigation technique. Histopathology and clinical follow-up results were reviewed for assessing the accuracy of procedures.
Adequate representative tissue sample could be retrieved in all the patients. No major procedure-related complications were encountered in any patient. Of the 25 procedures, 21 lesions were positive for malignancy and benign findings were observed in the other 4 lesions on histopathology. None of the patients required further biopsy in arriving at a final diagnosis. Overall diagnostic yield of the procedure was 100%.
Real time F-FDG PET/CT guidance for percutaneous biopsies of lung and mediastinal lesions is a feasible technique with potential utility in patients with previous inconclusive biopsy results. Advances in knowledge: F-FDG PET/CT guidance reduces the sampling errors by specifically targeting areas of viability and avoiding necrosis/atelectasis. A navigational tool like ARA is thought to help in accurately targeting these areas.
本研究旨在评估在自动机器人活检臂(ARA)引导下进行实时F-FDG PET/CT引导活检的可行性,并评价其对先前活检结果不确定的胸部病变的诊断效用。
对至少有一次先前活检结果不确定的患者进行PET/CT引导下的胸部病变活检。本研究共纳入25例患者(男:女 = 18例男性,7例女性;年龄范围13 - 75岁,平均53.7岁)。所有这些患者均在实时PET/CT引导下使用ARA(ROBIO-EX,印度钦奈Perfint医疗保健私人有限公司)针导航技术进行经皮针吸活检。回顾组织病理学和临床随访结果以评估操作的准确性。
所有患者均能获取足够的代表性组织样本。所有患者均未出现与操作相关的严重并发症。在这25例操作中,组织病理学检查显示21个病变为恶性阳性,另外4个病变为良性。所有患者在得出最终诊断时均无需进一步活检。该操作的总体诊断率为100%。
实时F-FDG PET/CT引导下对肺和纵隔病变进行经皮活检是一种可行的技术,对先前活检结果不确定的患者具有潜在效用。知识进展:F-FDG PET/CT引导通过特异性靶向存活区域并避免坏死/肺不张来减少采样误差。像ARA这样的导航工具被认为有助于准确靶向这些区域。